(2 years, 6 months ago)
Commons ChamberThe hon. Lady is of course right to talk about the importance of health inequalities. I hope that when she has had time to look at the plan she will see just how seriously the NHS and the Government take that. More broadly, I will have a lot more to say about tackling health inequalities shortly. Of course, the hon. Lady is right that there need to be alternatives to digital access for those who cannot easily access digital, be it through a web platform or the NHS app. There are alternatives in place, but I hope she agrees that for those who can use digital tools, we should make them part of the offering. The new “my planned care” service will be hugely important in providing more transparency than ever before, but also in helping people prepare for their surgical procedures. She may have heard me say earlier than one third of on-the-day cancellations of surgical procedures happen because people were not prepared.
I declare my interest as an NHS doctor and I echo much of what has been said by colleagues across the House about the workforce challenges.
As the Secretary of State said, covid has been a huge challenge to the NHS and it is a testament to NHS workers that cancer treatment was maintained at 94% of pre-pandemic levels throughout the pandemic and that 95% of people who needed cancer treatment started that within a month. However, I am sure the Secretary of State agrees that one month is a very long and frightening time to know that cancer is growing inside and that every day’s delay could be the day that costs your life. How does he intend to reduce that time and what will be his target from diagnosis to treatment?
I agree with my hon. Friend about the importance of the workforce. She is right to raise the importance of cancer care and to note that it has remained a huge priority for the NHS despite all the pressures of the pandemic. In the plan that we are publishing today, we have set out a number of cancer targets. They are all very ambitious with record amounts of investment. Once my hon. Friend has looked at the plan, I would be happy to discuss it further with her, either the cancer aspects or anything else.
(2 years, 8 months ago)
Commons ChamberI think both have a role to play. In the NHS and in social care, there is very frequent testing—lateral flow testing, in the case of the NHS, and often PCR testing—but I think vaccination has a role to play. At this point in time, many people still have two doses; that is rapidly changing. When they have a third dose or their booster dose, that gives them an even higher degree of protection.
I draw attention to my entry on the Register of Members’ Financial Interests. The Secretary of State is making a very clear argument for the need to do something; he talks about how a very small proportion of a much larger number of cases could overwhelm the NHS in the way that a larger proportion of a much smaller number of cases might not. However, we know that the NHS has a huge backlog of people awaiting diagnostic and operative procedures. What evidence does he have that mandating vaccines for NHS staff will help? Given that we know that vaccination does not particularly reduce transmission, and given what he has said about the importance of choice, why does he not think that it would be reasonable to offer medical staff and nursing staff the option of daily testing instead of vaccination, should they make that choice?
In coming to this decision, we held an extensive consultation with thousands of responses. Importantly, we also consulted with the NHS itself; as I shall touch on in a moment, it has weighed up the decision. My hon. Friend is right if she is suggesting that there may be some people who choose to leave the NHS rather than stay and be vaccinated—that is a choice for them to make, but there is also an issue of patient safety. That is also the view of the NHS. As I said in response to my right hon. Friend the Member for Haltemprice and Howden (Mr Davis), testing can be used alongside, but vaccinations help as well.
I want to talk about settings.
(2 years, 8 months ago)
Commons ChamberI do, of course, back any working together, whether it is of local government, the NHS or directors of public health, to help to combat this pandemic. They are doing a stellar job across the country, especially on vaccination.
One of the most significant harms over the last 18 months or so of restrictions has been the effect on our children and schoolchildren. I welcome the fact that instead of causing another pingdemic and having teachers and students out of school isolating, the Government have said that children will not need to isolate but will be able to use testing instead. Can my right hon. Friend confirm that that will be lateral flow testing and not PCR testing, for which they need an appointment? Can he tell us that we have enough tests if the scale of increase in cases is as he has said, and can he confirm to this House that he will resist any restrictions on schoolchildren?
My hon. Friend makes an important point. There is nothing more important in our society than our children. As a nation we have, like many other nations, learned a lot during the pandemic about some of the better ways to handle the concerns around the pandemic but better protect our schoolchildren. I am happy to confirm what she has said. If there is a positive case in a child, of course that individual child would isolate like anyone else, but any contacts of that child would not have to isolate. Instead, they can take lateral flow tests, not PCR tests.
(3 years, 1 month ago)
Commons ChamberAs I said in response to an earlier question, this is a huge priority for the Government and, again, I am pleased that the hon. Lady has raised the issue. It is an issue for her constituents and for constituents throughout the country. She referred to the research by Cancer Research UK. I am afraid that it is right: there are thousands of people who did not come forward. We can understand why, so let me say this again as it is so important: for anyone concerned, please do come forward. We have provided additional funding—more than £1 billion—for more diagnostics and we will continue to provide additional support.